Hamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 ,inter alia, to consider and approve Bonus Issue of shares, increase in ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hamps Bio Ltd has informed BSE that its Board of Directors will meet on 29 July 2025 to discuss several key items. The board will approve the date and notice of the 18th Annual General Meeting, along with the Board's Report and draft Annual Report for FY ending 31 March 2025. It will also consider the re-appointment of Mr. Shrenikkumar Mountkumar Shah as Whole-Time Director and the appointment of Ms. Shivali Rajpurohit as an Additional Independent Director. Importantly, the board will evaluate a proposal for a bonus issue of shares and consider increasing the company's authorised share capital with a corresponding amendment to the Memorandum of Association. All bonus and capital changes remain subject to shareholder and other requisite approvals.
The potential bonus issue and authorised share capital expansion are positive signals for shareholders, as bonus shares reward existing investors by increasing their shareholding proportion. However, no bonus ratio is disclosed yet, so investors should wait for the board's decision on 29 July for clarity on the size and terms.